MXPA05010935A - Parches de principio activo medicinal de aspecto discreto sobre la piel. - Google Patents

Parches de principio activo medicinal de aspecto discreto sobre la piel.

Info

Publication number
MXPA05010935A
MXPA05010935A MXPA05010935A MXPA05010935A MXPA05010935A MX PA05010935 A MXPA05010935 A MX PA05010935A MX PA05010935 A MXPA05010935 A MX PA05010935A MX PA05010935 A MXPA05010935 A MX PA05010935A MX PA05010935 A MXPA05010935 A MX PA05010935A
Authority
MX
Mexico
Prior art keywords
skin
active agent
person
medical active
less visible
Prior art date
Application number
MXPA05010935A
Other languages
English (en)
Spanish (es)
Inventor
Bracht Stefan
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33154271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05010935(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MXPA05010935A publication Critical patent/MXPA05010935A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
MXPA05010935A 2003-04-17 2004-04-08 Parches de principio activo medicinal de aspecto discreto sobre la piel. MXPA05010935A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10317692A DE10317692A1 (de) 2003-04-17 2003-04-17 Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
PCT/EP2004/003748 WO2004091590A1 (de) 2003-04-17 2004-04-08 Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut

Publications (1)

Publication Number Publication Date
MXPA05010935A true MXPA05010935A (es) 2005-11-25

Family

ID=33154271

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010935A MXPA05010935A (es) 2003-04-17 2004-04-08 Parches de principio activo medicinal de aspecto discreto sobre la piel.

Country Status (22)

Country Link
US (3) US10653636B2 (https=)
EP (1) EP1615628B1 (https=)
JP (2) JP5733875B2 (https=)
KR (1) KR101052127B1 (https=)
CN (1) CN100450472C (https=)
AT (1) ATE415954T1 (https=)
AU (1) AU2004229159B2 (https=)
BR (1) BRPI0409889B8 (https=)
CA (1) CA2522962C (https=)
CY (1) CY1108832T1 (https=)
DE (2) DE10317692A1 (https=)
DK (1) DK1615628T3 (https=)
ES (1) ES2320550T3 (https=)
IL (1) IL171399A (https=)
MX (1) MXPA05010935A (https=)
NZ (1) NZ543195A (https=)
PL (1) PL1615628T3 (https=)
PT (1) PT1615628E (https=)
RU (1) RU2336866C2 (https=)
SI (1) SI1615628T1 (https=)
WO (1) WO2004091590A1 (https=)
ZA (1) ZA200507034B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
CA2618519C (en) 2005-08-12 2016-09-27 Rick B. Yeager System and method for applying a reflectance modifying agent to improve the visual attractiveness of human skin
US8942775B2 (en) 2006-08-14 2015-01-27 Tcms Transparent Beauty Llc Handheld apparatus and method for the automated application of cosmetics and other substances
US8184901B2 (en) 2007-02-12 2012-05-22 Tcms Transparent Beauty Llc System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image
RU2452474C2 (ru) * 2006-12-01 2012-06-10 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
US20100062045A1 (en) 2006-12-01 2010-03-11 Nitto Denko Corporation Method for suppressing coloring of adhesive prepartion containing donepezil and method for reducing amounts of donepezil-related substances formed
EP2117721B8 (en) 2007-02-12 2012-08-08 YEAGER, Rick B. System and method for applying agent electrostatically to human skin
US10092082B2 (en) 2007-05-29 2018-10-09 Tcms Transparent Beauty Llc Apparatus and method for the precision application of cosmetics
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
KR20180018793A (ko) * 2015-06-22 2018-02-21 존슨 앤드 존슨 컨수머 인코포레이티드 피부에 효과를 제공하는 방법
CN113163930B (zh) * 2019-02-28 2024-11-08 松下知识产权经营株式会社 图像处理装置、图像处理方法以及片材

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE7529365U (de) 1976-01-08 Beiersdorf Ag, 2000 Hamburg Wund schnell verband
JPS55111416A (en) * 1979-02-20 1980-08-28 Taisho Pharmaceut Co Ltd Paster
US4594276A (en) * 1984-04-09 1986-06-10 Minnesota Mining And Manufacturing Company Printed, removable body tattoos on a translucent substrate
JPH0739566B2 (ja) 1986-02-21 1995-05-01 積水化学工業株式会社 医療用粘着テープもしくはシートの製造方法
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004510A (en) * 1989-01-30 1991-04-02 Panzhihua Iron & Steel Co. Process for manufacturing high strength railroad rails
DE4030465C2 (de) * 1990-09-26 1994-06-01 Ruschke Mona Pflaster
US5120325A (en) * 1991-06-12 1992-06-09 Fleshtones Products Co., Inc. Color-matched sterile adhesive bandages containing melanin-like pigment composition
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
JPH07206624A (ja) 1994-01-20 1995-08-08 Shiseido Co Ltd 皮膚外用剤
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
DE19519593C1 (de) * 1995-05-29 1996-08-29 Horstmann Michael Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung
BR9709920A (pt) * 1996-06-20 2000-01-11 Lavipharm Sa Dispositivo para tratamento tópico da acne e seu método de manufatura
US6025535A (en) * 1996-10-28 2000-02-15 The Procter & Gamble Company Topsheet for absorbent articles exhibiting improved masking properties
JPH11116470A (ja) * 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
ES2336054T3 (es) 1998-12-18 2010-04-07 Alza Corporation Dispositivo transparente para la administracion transdermica de nicotina.
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
JP4349772B2 (ja) 2000-04-12 2009-10-21 ザ プロクター アンド ギャンブル カンパニー 局所適用に好適な予め成形されたシート貼付具
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US8586079B2 (en) * 2002-06-21 2013-11-19 Graphic Productions Inc. Promotional simulation for transdermal patch sampler
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut

Also Published As

Publication number Publication date
DE10317692A1 (de) 2004-11-11
US10646453B2 (en) 2020-05-12
JP5733875B2 (ja) 2015-06-10
CA2522962C (en) 2011-11-01
KR20050114724A (ko) 2005-12-06
US20070116751A1 (en) 2007-05-24
EP1615628B1 (de) 2008-12-03
DE502004008582D1 (de) 2009-01-15
AU2004229159B2 (en) 2010-01-28
BRPI0409889A (pt) 2006-05-23
ES2320550T3 (es) 2009-05-25
IL171399A (en) 2015-02-26
RU2005129528A (ru) 2006-05-10
BRPI0409889B1 (pt) 2019-12-17
CA2522962A1 (en) 2004-10-28
DK1615628T3 (da) 2009-04-06
ATE415954T1 (de) 2008-12-15
PL1615628T3 (pl) 2009-06-30
JP2012092133A (ja) 2012-05-17
EP1615628A1 (de) 2006-01-18
RU2336866C2 (ru) 2008-10-27
KR101052127B1 (ko) 2011-07-26
ZA200507034B (en) 2006-05-31
US20190160017A1 (en) 2019-05-30
US11426358B2 (en) 2022-08-30
CN1826103A (zh) 2006-08-30
NZ543195A (en) 2009-04-30
JP2006523637A (ja) 2006-10-19
AU2004229159A1 (en) 2004-10-28
BRPI0409889B8 (pt) 2021-05-25
US10653636B2 (en) 2020-05-19
US20200206147A1 (en) 2020-07-02
CN100450472C (zh) 2009-01-14
HK1079455A1 (zh) 2006-04-07
SI1615628T1 (sl) 2009-04-30
CY1108832T1 (el) 2014-07-02
WO2004091590A1 (de) 2004-10-28
PT1615628E (pt) 2009-03-11

Similar Documents

Publication Publication Date Title
MXPA05010935A (es) Parches de principio activo medicinal de aspecto discreto sobre la piel.
USD476488S1 (en) Applique
DE502006003104D1 (de) Sicherheitsdokument
FI973713A7 (fi) Karboksi- tai tetratsolipääteryhmiä sisältävät dialkyylieetterit
ATE359040T1 (de) Implantat mit proliferationshemmender substanz
AU2002305408A1 (en) Property/casual insurance and techniques
AU2003300352A1 (en) Emergency medical devices with multiple displays
CA2256959A1 (en) Decorative lighting laminate
HUP0003912A2 (hu) Abszorbens termék
BR0307582A (pt) Substrato de processamento e/ou superfìcie de suporte e método de fabricação do mesmo
AU3290500A (en) Glove
BR0010917B1 (pt) vidraÇa isolante usada em uma porta de recinto refrigerado.
FR2870453B1 (fr) Film de vernis a ongles reticule
DE602004004817D1 (de) Myo-inositol hexaphosphat zur topischen verwendung
AU7526800A (en) Sight locking device
BR0108004A (pt) Método de aumento de estado de alerta por administração de um vomeroferina, e dispositivos de alarme de emissão de vomeroferina
AU2003212558A1 (en) Active matrix electroluminescent display devices, and their manufacture
USD499148S1 (en) Safety label assembly
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
WO2003022012A1 (en) Light emitting element, and display unit and illuminating device using the light emitting element
SE0200326D0 (sv) Funktionspanel
AU2003240253A1 (en) Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.
Ahola Effects of social and physical housing environment on the welfare in silver foxes (Vulpes vulpes)
BR0211533A (pt) Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas

Legal Events

Date Code Title Description
FG Grant or registration